A mathematical model suggests that existing HPA-targeting drugs failed in clinical trials for mood disorders because the ...

Total serum cortisol and CBG levels were higher in subjects taking oral estrogens than in controls (P <0.001); however, levels in subjects taking transdermal estrogen were similar to controls.